James A. Wohlschlegel

James Akira Wohlschlegel

Professor, Biological Chemistry, University of California Los Angeles

310-267-0585

Mailing Address:
UCLA Biol Chem
Box 951737
Los Angeles, CA 90095

Office Address:
BSRB 377A
615 Charles E. Young Dr. South
Los Angeles, CA 90095

Office Phone Number:
310-794-7955

Affiliations

Member, Biochemistry, Biophysics & Structural Biology GPB Home AreaCell & Developmental Biology GPB Home AreaGene Regulation GPB Home AreaI3T ThemeJCCC Gene Regulation Program AreaUCLA-DOE Institute for Genomics & Proteomics

Research Interests

Signaling networks have emerged as the underlying regulatory system by which the many biological pathways required for sustaining life are coordinated. My laboratory uses a combination of biochemistry and proteomic mass spectrometry to understand the signaling networks mediated by the ubiquitin family of small protein modifications. Specifically, we are examining the role of two members of this family, ubiquitin and SUMO, in regulating key nuclear processes. Importantly, the deregulation of these two modification systems has been linked to the pathogenesis of many diseases including cancer, neurodegenerative diseases, and immune system disorders. Ubiquitin is a 76 amino acid protein that regulates the abundance and activity of a large number of cellular factors through its covalent attachment to lysines in target proteins. The specificity of this modification system is generated by a large family of ubiquitin ligases, each of which target a specific set of substrates for modification. We are currently characterizing a subset of these ubiquitin ligases that have been implicated in tumorigenesis. Using a combination of proteomic and biochemical tools, we are identifying the substrates of these ligases and working to understand how altering the modification state of these substrates can influence tumor progression. SUMO is another member of the ubiquitin family of small protein modifiers that plays a critical regulatory role in a number of different biological processes. We previously developed a series of proteomic tools that enabled us to characterize different aspects of this signaling pathway. These findings form the basis for ongoing work in my laboratory aimed at understanding how SUMO-regulated protein networks influence chromatin structure, cell cycle progression and genome stability and how misregulation of this pathway can play a critical role in tumorigenesis.

Biography

James Wohlschlegel received his B.S. in Biochemistry from Texas A&M University (College Station, TX) in 1997. He then went to graduate school at Harvard Medical School (Boston, MA) where he studied protein complexes regulating the initiation of DNA replication in the laboratory of Anindya Dutta. After completing his Ph.D. in 2002, James went to the Scripps Research Institute (La Jolla, CA) for postdoctoral training under the co-mentorship of John Yates (proteomic mass spectrometry) and Steven Reed (cell cycle regulation). James joined the Department of Biological Chemistry as an assistant professor in 2006.

Publications

A selected list of publications: